Chemed Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 12.94, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Chemed in Jun 30 2026 quarter, has decreased to 28 days, compared to 29 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 81 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 720 to 882.

What is Receivable Turnover Ratio?
What is Chemed Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHE Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	2.03 %	-24.62 %	6.67 %	9.72 %	-0.04 %
Y / Y Revenue Change	8.8 %	1.63 %	-0.1 %	3.09 %	3.85 %
Receivable Turnover Ratio (TTM)	12.94	12.73	11.65	11.8	11.98
CHE's Total Ranking	# 882	# 720	# 280	# 948	# 391
Accounts Receivable average collection period days	28	29	31	31	30
Seq. Receivable Change	-12.46 %	18.02 %	-15.31 %	16.6 %	-35.33 %
Seq. Revenue Change	2.39 %	2.84 %	2.31 %	0.99 %	-4.35 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 9
Healthcare Sector	# 82
Overall Market	# 882

Receivable Turnover Ratio Statistics
High	Average	Low
18.22	14.64	11.47
(Jun 30 2021)		(Jun 30 2015)

CHE Company Profile • Back to CHE Efficiency Comparisons • Compare CHE Receivables Turnover Ratio to its Competitors

Financial Statements
Chemed's Accounts Receivable	$ 189 Millions	Visit CHE's Balance sheet
Chemed's Sales TTM	$ 2,595 Millions	Visit CHE's Income Statement
Sources of CHE's Revenues		Visit CHE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CHE's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CHE's Growth Rates	CHE's Roa	CHE's Inventory Turnover Ratio	CHE's Dividend Comparisons
CHE's Profitability Ratios	CHE's Roi	CHE's Asset Turnover Ratio	CHE's Dividend Growth
CHE's Valuation Ratios	CHE's Roe	CHE's Financial Strength Ratios	CHE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Bioadaptives Inc	35.76	$ 0.026 Millions	$ 0.001 Millions
Lifevantage Corp	35.05	$ 180.947 Millions	$ 5.162 Millions
Electrocore Inc	34.09	$ 36.527 Millions	$ 1.072 Millions
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Mangoceuticals Inc	31.43	$ 0.315 Millions	$ 0.010 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Jaguar Health Inc	30.23	$ 27.815 Millions	$ 0.920 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Metagenomi Therapeutics Inc	25.05	$ 13.561 Millions	$ 0.541 Millions
Sonida Senior Living Inc	22.59	$ 525.973 Millions	$ 23.283 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Ginkgo Bioworks Holdings Inc	20.32	$ 111.863 Millions	$ 5.506 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Neuraxis Inc	15.53	$ 5.316 Millions	$ 0.342 Millions
Agenus Inc	15.44	$ 132.693 Millions	$ 8.595 Millions
Longeveron Inc	15.03	$ 1.187 Millions	$ 0.079 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Dar Bioscience Inc	14.57	$ 1.345 Millions	$ 0.092 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
China Pharma Holdings Inc	14.46	$ 3.914 Millions	$ 0.271 Millions

Date modified: 2026-09-05T07:01:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.